BioTime (BTX) Tops Q2 EPS by 5c

BioTime (NYSE: BTX) reported Q2 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $557 thousand.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance